Zhenhong Guo

Zhenhong Guo

Auto-generated profile, based on publicly available information

Zhenhong Guo

National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China 4

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MLMingyu Liu
Mingyu Liu
CWChong Wu
Chong Wu
SLShufeng Luo
Shufeng Luo
QHQiaomin Hua
Qiaomin Hua
HCHaitian Chen
Haitian Chen
LZLimin Zheng
Limin Zheng
The spleen is an important site of hematopoietic stem/progenitor cell (HSPC) preconditioning and tumor-promoting myeloid cell generation in cancer, but the regulatory mechanism remains unclear. Here, we found that PKR-like endoplasmic reticulum kinase (PERK) mediated HSPC reprogramming into committed MDSC precursors in the spleen via PERK–ATF4–C/EBPβ signaling. Pharmacological and genetic inhibition of this pathway in murine and human HSPCs prevented their myeloid descendant cells from becoming MDSCs even with subsequent exposure to tumor microenvironment (TME) factors. In mice, the selective delivery of PERK antagonists to the spleen was not only sufficient but more effective than the tumor-targeted strategy in preventing MDSC activation in the tumor, leading to profound TME reshaping and tumor regression. Clinically, HSPCs in the spleen of cancer patients exhibit increased PERK signaling correlated with enhanced myelopoiesis. Our findings indicate that PERK-mediated HSPC preconditioning plays a crucial role in MDSC generation, suggesting novel spleen-targeting therapeutic opportunities for restraining the tumor-promoting myeloid response at its source.

1 May 2008 in Molecular Immunology
Verified
Journal Article
Closed access
SXSheng Xia
Sheng Xia
ZGZhenhong Guo
Zhenhong Guo
YYYushi Yao
Yushi Yao
XXXiongfei Xu
Xiongfei Xu
HYHai Yi
Hai Yi
XCXuetao Cao
Xuetao Cao